Notify me when Cantor Fitzgerald & Co. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| OKUR | OnKure Therapeutics Inc. | Class A Common Stock, par value $0.0001 per share | 5.2% | $1.61M | 670K | Cantor Fitzgerald Securities | Jun 30, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|